19.10.2016 13:27:34
|
St. Jude Medical Withdraws FY16 Guidance Due To Merger With Abbott - Quick Facts
(RTTNews) - While reporting its financial results for the third quarter today, Medical device maker St. Jude Medical, Inc. (STJ) said it has withdrawn its financial guidance for fiscal 2016 due to its planned merger with Abbott Laboratories (ABT).
In April, Abbott said it has agreed to acquire St. Jude Medical. Under the agreement, St. Jude Medical shareholders will receive $46.75 in cash and 0.8708 shares of Abbott common stock, representing total consideration of approximately $85 per share. This represents a total transaction equity value of $25 billion.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu St. Jude Medical Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |